SMURF1 and cancer: Thus identifying mechanisms to modulate the Smurf1 E3 ligase activity could provide a novel therapeutic avenue for cancer by targeting both early phases of tumorigenesis and later stages of metastasis, thereby attacking cancer in two phases and enhancing cancer patient survival.